1. ‣Investor Information

About UsAbout_Us.htmlshapeimage_5_link_0
About Usshapeimage_6_link_0
Investor RelationsNews.htmlshapeimage_7_link_0
NewsContact_Us.htmlshapeimage_8_link_0
About UsContact_Us.htmlshapeimage_9_link_0

TrovaGene Inc., 11055 Flintkote Ave., Suite B, San Diego, CA 92121

Investor RelationsScience.htmlshapeimage_10_link_0
NewsProduct_Development.htmlshapeimage_11_link_0

» Investor Relations

» Press Releases

» Charters

  1. » Code of Business Conduct

  2. » Audit Committee

  3. » Compensation Committee

TROV.PK

TrovaGene is currently traded on the Pink Sheets as TROV.PK.  The company is currently working on the documentation necessary to meet SEC requirements for relisting.

For additional information please contact:

ir@trovagene.com


March 2, 2010

TrovaGene, Inc. Announces Name and Ticker Symbol Change

TrovaGene, Inc. (TROV.PK), formerly Xenomics, Inc. (XNOM.PK) a developer of transrenal molecular diagnostics, announced today that it has changed its name from Xenomics, Inc. to TrovaGene, Inc. and re-domesticated its state of incorporation to Delaware from Florida. The Company’s stock symbol has been changed to TROV effective March 1, 2010.

» read more

» download